Cargando…

Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level

Authors summarize in this brief review results of European discussion, held on ETA-CRN Meeting in Lisbon, 2009, on the American Thyroid Association Medullary Thyroid Cancer (MTC) Guidelines published in the same year and focus on the timing of prophylactic thyroidectomy. ATA 2009 guidelines classifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarzab, Barbara, Szpak-Ulczok, Sylwia, Wloch, Jan, Czarniecka, Agnieszka, Krajewska, Jolanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599705/
https://www.ncbi.nlm.nih.gov/pubmed/23514096
http://dx.doi.org/10.1186/1756-6614-6-S1-S9
_version_ 1782263032520376320
author Jarzab, Barbara
Szpak-Ulczok, Sylwia
Wloch, Jan
Czarniecka, Agnieszka
Krajewska, Jolanta
author_facet Jarzab, Barbara
Szpak-Ulczok, Sylwia
Wloch, Jan
Czarniecka, Agnieszka
Krajewska, Jolanta
author_sort Jarzab, Barbara
collection PubMed
description Authors summarize in this brief review results of European discussion, held on ETA-CRN Meeting in Lisbon, 2009, on the American Thyroid Association Medullary Thyroid Cancer (MTC) Guidelines published in the same year and focus on the timing of prophylactic thyroidectomy. ATA 2009 guidelines classified RET protooncogene mutation carriers into 4 levels: A, B, C, D. ATA for prophylactic thyroidectomy were generally independent of the serum calcitonin (Ct) concentration but based on a priori risk levels. This was well accepted as the important novelty was to delineate risk level specially for RET 634 mutation (level C). In the ATA Guidelines total prophylactic thyroidectomy below age 5 years was recommended in RET 634 mutation carriers regardless of Ct status. However, some European experts favored to base the decision not only on the results of DNA testing but also on the going Ct level. The European discussion reflected divergent opinions and indicated the need of publication of European experience instead of arbitrary opinions. It was stressed that patients carrying the same RET mutation present heterogenic progression to the clinically overt medullary thyroid cancer, even in the same family. Thus, in summary, the ATA MTC guidelines constituted a positive stimulus to publish further evidence for Ct-guided pre-emptive thyroidectomy for RET gene mutation carriers and the conclusion is drawn on the basis of experience expressed in Lisbon and published later evidence that the integrated algorithm based on age - Ct - type of RET mutation should be considered in the decision of pre-emptive thyroidectomy.
format Online
Article
Text
id pubmed-3599705
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35997052013-03-25 Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level Jarzab, Barbara Szpak-Ulczok, Sylwia Wloch, Jan Czarniecka, Agnieszka Krajewska, Jolanta Thyroid Res Review Authors summarize in this brief review results of European discussion, held on ETA-CRN Meeting in Lisbon, 2009, on the American Thyroid Association Medullary Thyroid Cancer (MTC) Guidelines published in the same year and focus on the timing of prophylactic thyroidectomy. ATA 2009 guidelines classified RET protooncogene mutation carriers into 4 levels: A, B, C, D. ATA for prophylactic thyroidectomy were generally independent of the serum calcitonin (Ct) concentration but based on a priori risk levels. This was well accepted as the important novelty was to delineate risk level specially for RET 634 mutation (level C). In the ATA Guidelines total prophylactic thyroidectomy below age 5 years was recommended in RET 634 mutation carriers regardless of Ct status. However, some European experts favored to base the decision not only on the results of DNA testing but also on the going Ct level. The European discussion reflected divergent opinions and indicated the need of publication of European experience instead of arbitrary opinions. It was stressed that patients carrying the same RET mutation present heterogenic progression to the clinically overt medullary thyroid cancer, even in the same family. Thus, in summary, the ATA MTC guidelines constituted a positive stimulus to publish further evidence for Ct-guided pre-emptive thyroidectomy for RET gene mutation carriers and the conclusion is drawn on the basis of experience expressed in Lisbon and published later evidence that the integrated algorithm based on age - Ct - type of RET mutation should be considered in the decision of pre-emptive thyroidectomy. BioMed Central 2013-03-14 /pmc/articles/PMC3599705/ /pubmed/23514096 http://dx.doi.org/10.1186/1756-6614-6-S1-S9 Text en Copyright ©2013 Jarzab et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Jarzab, Barbara
Szpak-Ulczok, Sylwia
Wloch, Jan
Czarniecka, Agnieszka
Krajewska, Jolanta
Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level
title Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level
title_full Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level
title_fullStr Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level
title_full_unstemmed Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level
title_short Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level
title_sort timing and criteria for prophylactic thyroidectomy in asymptomatic ret carriers – the role of ct serum level
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599705/
https://www.ncbi.nlm.nih.gov/pubmed/23514096
http://dx.doi.org/10.1186/1756-6614-6-S1-S9
work_keys_str_mv AT jarzabbarbara timingandcriteriaforprophylacticthyroidectomyinasymptomaticretcarrierstheroleofctserumlevel
AT szpakulczoksylwia timingandcriteriaforprophylacticthyroidectomyinasymptomaticretcarrierstheroleofctserumlevel
AT wlochjan timingandcriteriaforprophylacticthyroidectomyinasymptomaticretcarrierstheroleofctserumlevel
AT czarnieckaagnieszka timingandcriteriaforprophylacticthyroidectomyinasymptomaticretcarrierstheroleofctserumlevel
AT krajewskajolanta timingandcriteriaforprophylacticthyroidectomyinasymptomaticretcarrierstheroleofctserumlevel